The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2015

Filed:

Sep. 24, 2012
Applicants:

Jonathan Michael Gerber, Baltimore, MD (US);

Richard John Jones, Baltimore, MD (US);

Inventors:

Jonathan Michael Gerber, Baltimore, MD (US);

Richard John Jones, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/095 (2010.01); C12N 5/09 (2010.01); G01N 33/574 (2006.01); C12Q 1/32 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/32 (2013.01); G01N 33/57426 (2013.01); G01N 2800/54 (2013.01);
Abstract

Using the methods of the present invention, intermediate (int) levels of aldehyde dehydrogenase (ALDH) activity reliably distinguished leukemic CD34CD38cells capable of engrafting immunodeficient mice, from residual normal hematopoietic stem cells that exhibited relatively higher ALDH activity. Minimal residual disease (MRD) detected during complete remission was enriched for the CD34CD38ALDHleukemic cells, and the presence of these cells after therapy highly correlated with subsequent clinical relapse. The methods of the present invention can distinguish normal from leukemic CD34CD38cells, and identifies those AML cells associated with relapse. Methods of prediction of relapse of AML patients and methods of treatment are also provided.


Find Patent Forward Citations

Loading…